A randomized controlled trial to evaluate the effectiveness of genetic cancer risk prediction for female screening non-responders

A randomized controlled trial to evaluate the effectiveness of genetic cancer risk prediction for female screening non-responders - Commercial genetic cancer risk feedback RCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031709

Enrollment

160

Registered

2018-03-13

Start date

2018-03-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer prevention behavior

Interventions

Commercial genetic cancer risk prediction and health education for cancer prevention Health education for cancer prevention

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. 45-49 years old women 2. No past history of cancer 3. Breast and cervical cancer screening non-responders 4. Individuals who can attend the study explanation meeting 5. Individuals who sign the consent document for explanation of this study 6. Individuals who consent to share the genetic information with researchers 7. Individuals who consent to the follow-up survey regarding the cancer screenings and lifestyle

Exclusion criteria

Exclusion criteria: 1. Past history of cancer

Design outcomes

Primary

Measure	Time frame
Breast and cervical cancer screening rate	—

Secondary

Measure	Time frame
Lifestyle change (BMI, physical activity, dietary pattern), psychological effect	—

Countries

Japan

Contacts

Public ContactSadao Suzuki

Nagoya City University Graduate School of Medical Sciences Department of Public Health

taisitu@med.nagoya-cu.ac.jp052-853-8177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026